Isocyclamine
| Isocyclamine | |
|---|---|
 | |
| Molecular structure via molpic based on CDK |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 127.23 g/mol [1] |
| Predicted LogP | 2.4 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C8H17N [1] |
| IUPAC name | 1-cyclopentylpropan-2-amine [1] |
| SMILES | CC(CC1CCCC1)N [1] |
| InChI | InChI=1S/C8H17N/c1-7(9)6-8-4-2-3-5-8/h7-8H,2-6,9H2,1H3 [1] |
| InChIKey | JEJKKTYNUKTPTJ-UHFFFAOYSA-N [1] |
Isocyclamine (also known as α-Methylcyclopentaneethanamine, Dtxcid301736598, 962-542-2, Schembl3901737, Schembl9213354, Schembl27689827, I+/--Methylcyclopentaneethanamine, 2-cyclopentyl-1-methyl-ethylamine, AAA10523 or AR-1K1985) is a
Chemistry
Stereochemistry []
Isocyclamine is a racemic mixture of the enantiomers.
| Stereoisomerism |
|---|
| Stereoisomer enumberation with rdkit |
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 7743, Isocyclamine. Accessed August 23, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/7743
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Isocyclamine. UNII: DY4LH10D2X. Global Substance Registration System. Accessed August 23, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/DY4LH10D2X